Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, Faustin A, Spino-Keeton M, Roberts LG, Maloku E, Drexler SA, Liechty BL, Pisapia D, Krasnozhen-Ratush O, Rosenblum M, Shroff S, Boué DR, Davidson C, Mao Q, Suchi M, North P, Hopp A, Segura A, Jarzembowski JA, Parsons L, Johnson MD, Mobley B, Samore W, McGuone D, Gopal PP, Canoll PD, Horbinski C, Fullmer JM, Farooqui MS, Gokden M, Wadhwani NR, Richardson TE, Umphlett M, Tsankova NM, DeWitt JC, Sen C, Placantonakis DG, Pacione D, Wisoff JH, Teresa Hidalgo E, Harter D, William CM, Cordova C, Kurz SC, Barbaro M, Orringer DA, Karajannis MA, Sulman EP, Gardner SL, Zagzag D, Tsirigos A, Allen JC, Golfinos JG, Snuderl M. Galbraith K, et al. Among authors: umphlett m. Neurooncol Adv. 2023 Jun 26;5(1):vdad076. doi: 10.1093/noajnl/vdad076. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37476329 Free PMC article.
The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomas.
Vij M, Yokoda RT, Rashidipour O, Tran I, Vasudevaraja V, Snuderl M, Yong RL, Cobb WS, Umphlett M, Walker JM, Tsankova NM, Richardson TE. Vij M, et al. Among authors: umphlett m. Neurooncol Adv. 2023 May 29;5(1):vdad069. doi: 10.1093/noajnl/vdad069. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37324217 Free PMC article.
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma.
Richardson TE, Yokoda RT, Rashidipour O, Vij M, Snuderl M, Brem S, Hatanpaa KJ, McBrayer SK, Abdullah KG, Umphlett M, Walker JM, Tsankova NM. Richardson TE, et al. Among authors: umphlett m. Neurooncol Adv. 2023 Jul 12;5(1):vdad085. doi: 10.1093/noajnl/vdad085. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37554222 Free PMC article.
Tumor immune microenvironment in brain metastases from gynecologic malignancies.
Gill CM, D'Andrea MR, Tomita S, Suhner J, Umphlett M, Zakashansky K, Blank SV, Tsankova N, Shrivastava RK, Fowkes M, Kolev V. Gill CM, et al. Among authors: umphlett m. Cancer Immunol Immunother. 2021 Oct;70(10):2951-2960. doi: 10.1007/s00262-021-02909-4. Epub 2021 Mar 13. Cancer Immunol Immunother. 2021. PMID: 33713153 Free PMC article.
Recurrent IDH mutations in high-grade meningioma.
Gill CM, Loewenstern J, Rutland JW, Arib H, Francoeur N, Wang YC, Fishman N, Pain M, Umphlett M, Kinoshita Y, McBride RB, Bederson J, Donovan M, Smith M, Sebra R, Shrivastava RK, Fowkes M. Gill CM, et al. Among authors: umphlett m. Neuro Oncol. 2020 Jul 7;22(7):1044-1045. doi: 10.1093/neuonc/noaa065. Neuro Oncol. 2020. PMID: 32179909 Free PMC article. No abstract available.
29 results